Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/48259
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rico-Bautista, Elizabeth | en_US |
dc.contributor.author | Negrín-Martínez, Ciro | en_US |
dc.contributor.author | Novoa Mogollón, Francisco | en_US |
dc.contributor.author | Fernández-Perez, Leandro | en_US |
dc.contributor.author | Flores-Morales, Amilcar | en_US |
dc.date.accessioned | 2018-11-23T20:13:21Z | - |
dc.date.available | 2018-11-23T20:13:21Z | - |
dc.date.issued | 2004 | en_US |
dc.identifier.issn | 0014-4827 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/48259 | - |
dc.description.abstract | Transient activation of the signal transducers and activators of transcription (STAT) proteins in response to growth hormone (GH) and other type II cytokines plays a pivotal role on specific gene transcription. The negative regulation of STATs seems to be exerted at the GH receptor (GHR)/Janus Kinase (JAK) complex and involves two main mechanisms: (1) the GH-induced ubiquitination/internalization of GHR and (2) the action of SOCS proteins. Since GH regulates cellular cytoskeleton with potential implications in GH signaling, we investigated the effects of actin cytoskeleton disruption on the kinetics of GH-activated GHR/Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) signaling pathway. Disruption of the actin-based cytoskeleton with cytochalasin D (CytoD) did not affect the rapid GH induction of JAK2 and STAT5 activities. However, pretreatment of BRL-4 cells with CytoD prolonged both, JAK2/STAT5 tyrosine phosphorylation and STAT5 DNA binding activity, for at least 2 h. Our results demonstrated that the synthesis of the several SOCS proteins (SOCS-1, -2, and -3) was not affected by treatment of the cells with CytoD. On the other hand, the inhibitory actions of SOCS 1, 2, and -3 on GH-induced STAT5 reporter activity were partially blocked by disruption of the cytoskeleton. Disassembly of the actin filaments by CytoD is accompanied by accumulation of ubiquitinated forms of GHR but it does not affect GHR internalization. We conclude that the integrity of the actin cytoskeleton network plays an essential role in the negative regulation of GHR/JAK2/STAT5 signaling pathway by facilitating the GHR ubiquitination/degradation through mechanisms acting downstream SOCS. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Experimental cell research | en_US |
dc.source | Experimental Cell Research[ISSN 0014-4827],v. 294, p. 269-280 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 3201 Ciencias clínicas | en_US |
dc.subject.other | Tyrosyl Phosphorylation | en_US |
dc.subject.other | Endoplasmic-Reticulum | en_US |
dc.subject.other | Cytokine Signaling-2 | en_US |
dc.subject.other | Protein-Synthesis | en_US |
dc.subject.other | Epithelial-Cells | en_US |
dc.subject.other | Gene-Expression | en_US |
dc.subject.other | Receptor | en_US |
dc.subject.other | Endocytosis | en_US |
dc.subject.other | System | en_US |
dc.subject.other | Jak2 | en_US |
dc.title | Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.yexcr.2003.11.017 | en_US |
dc.identifier.scopus | 1242339600 | - |
dc.identifier.isi | 000220028300026 | - |
dc.contributor.authorscopusid | 6508139241 | - |
dc.contributor.authorscopusid | 6505525090 | - |
dc.contributor.authorscopusid | 12786120600 | - |
dc.contributor.authorscopusid | 6506777525 | - |
dc.contributor.authorscopusid | 57203543352 | - |
dc.description.lastpage | 280 | en_US |
dc.description.firstpage | 269 | en_US |
dc.relation.volume | 294 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | 3599226 | - |
dc.contributor.daisngid | 11865715 | - |
dc.contributor.daisngid | 6408279 | - |
dc.contributor.daisngid | 795544 | - |
dc.contributor.daisngid | 617657 | - |
dc.description.numberofpages | 12 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Rico-Bautista, E | - |
dc.contributor.wosstandard | WOS:Negrin-Martinez, C | - |
dc.contributor.wosstandard | WOS:Novoa-Mogollon, J | - |
dc.contributor.wosstandard | WOS:Fernandez-Perez, L | - |
dc.contributor.wosstandard | WOS:Flores-Morales, A | - |
dc.date.coverdate | Marzo 2004 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.jcr | 4,007 | - |
dc.description.jcrq | Q1 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.orcid | 0000-0003-3629-8120 | - |
crisitem.author.orcid | 0000-0001-7802-465X | - |
crisitem.author.orcid | 0000-0002-0828-8921 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Novoa Mogollón,Francisco | - |
crisitem.author.fullName | Fernández Pérez, Leandro Francisco | - |
crisitem.author.fullName | Flores Morales,Amilcar | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
19
checked on Nov 17, 2024
WEB OF SCIENCETM
Citations
18
checked on Nov 17, 2024
Page view(s)
69
checked on Aug 31, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.